LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | CP724714 | 0.12 | uM | LJP5 | 1 | A11 | 72 | hr | 1401 | 2636 | 4223 | 0.6242 | 0.4375 |
| SK-BR-3 | CP724714 | 0.12 | uM | LJP5 | 2 | A11 | 72 | hr | 1401 | 2942 | 4223 | 0.6967 | 0.5460 |
| SK-BR-3 | CP724714 | 0.12 | uM | LJP5 | 3 | A11 | 72 | hr | 1401 | 2866 | 4223 | 0.6787 | 0.5190 |
| SK-BR-3 | CP466722 | 0.12 | uM | LJP5 | 1 | I11 | 72 | hr | 1401 | 5014 | 4223 | 1.1873 | 1.2803 |
| SK-BR-3 | CP466722 | 0.12 | uM | LJP5 | 2 | I11 | 72 | hr | 1401 | 3867 | 4223 | 0.9157 | 0.8738 |
| SK-BR-3 | CP466722 | 0.12 | uM | LJP5 | 3 | I11 | 72 | hr | 1401 | 4017 | 4223 | 0.9512 | 0.9270 |
| SK-BR-3 | Crizotinib | 0.12 | uM | LJP5 | 1 | A23 | 72 | hr | 1401 | 3680 | 4223 | 0.8714 | 0.8075 |
| SK-BR-3 | Crizotinib | 0.12 | uM | LJP5 | 2 | A23 | 72 | hr | 1401 | 3934 | 4223 | 0.9316 | 0.8975 |
| SK-BR-3 | Crizotinib | 0.12 | uM | LJP5 | 3 | A23 | 72 | hr | 1401 | 4296 | 4223 | 1.0173 | 1.0258 |
| SK-BR-3 | Momelotinib | 0.12 | uM | LJP5 | 1 | P11 | 72 | hr | 1401 | 3926 | 4223 | 0.9297 | 0.8947 |
| SK-BR-3 | Momelotinib | 0.12 | uM | LJP5 | 2 | P11 | 72 | hr | 1401 | 4056 | 4223 | 0.9604 | 0.9408 |
| SK-BR-3 | Momelotinib | 0.12 | uM | LJP5 | 3 | P11 | 72 | hr | 1401 | 4451 | 4223 | 1.0540 | 1.0808 |
| SK-BR-3 | Dasatinib | 0.12 | uM | LJP5 | 1 | D05 | 72 | hr | 1401 | 4250 | 4223 | 1.0064 | 1.0095 |
| SK-BR-3 | Dasatinib | 0.12 | uM | LJP5 | 2 | D05 | 72 | hr | 1401 | 4665 | 4223 | 1.1046 | 1.1566 |
| SK-BR-3 | Dasatinib | 0.12 | uM | LJP5 | 3 | D05 | 72 | hr | 1401 | 4491 | 4223 | 1.0634 | 1.0950 |
| SK-BR-3 | Dasatinib | 0.12 | uM | LJP6 | 1 | I05 | 72 | hr | 1401 | 4163 | 4223 | 0.9858 | 0.9787 |
| SK-BR-3 | Dasatinib | 0.12 | uM | LJP6 | 2 | I05 | 72 | hr | 1401 | 4041 | 4223 | 0.9569 | 0.9355 |
| SK-BR-3 | Dasatinib | 0.12 | uM | LJP6 | 3 | I05 | 72 | hr | 1401 | 3351 | 4223 | 0.7935 | 0.6909 |
| SK-BR-3 | Dovitinib | 0.12 | uM | LJP5 | 1 | E23 | 72 | hr | 1401 | 3080 | 4223 | 0.7293 | 0.5949 |
| SK-BR-3 | Dovitinib | 0.12 | uM | LJP5 | 2 | E23 | 72 | hr | 1401 | 3529 | 4223 | 0.8356 | 0.7540 |
| SK-BR-3 | Dovitinib | 0.12 | uM | LJP5 | 3 | E23 | 72 | hr | 1401 | 3546 | 4223 | 0.8397 | 0.7600 |
| SK-BR-3 | Enzastaurin | 0.12 | uM | LJP5 | 1 | D17 | 72 | hr | 1401 | 4093 | 4223 | 0.9692 | 0.9539 |
| SK-BR-3 | Enzastaurin | 0.12 | uM | LJP5 | 2 | D17 | 72 | hr | 1401 | 4458 | 4223 | 1.0556 | 1.0833 |
| SK-BR-3 | Enzastaurin | 0.12 | uM | LJP5 | 3 | D17 | 72 | hr | 1401 | 4153 | 4223 | 0.9834 | 0.9752 |
| SK-BR-3 | Erlotinib | 0.12 | uM | LJP5 | 1 | M23 | 72 | hr | 1401 | 3725 | 4223 | 0.8821 | 0.8235 |